Analysts have set 12-month price targets for Avidity Biosciences, revealing an average target of $66.31, a high estimate of ...

In a nutshell All modern humans share DNA from two ancient populations that split 1.5 million years ago and reunited through ...

HC Bioscience is shutting down after conducting preclinical models for a transfer RNA (tRNA) asset designed to treat ...

With the long-term goal of creating living cells from non-living components, scientists in the field of synthetic biology ...

Nobel Laureate and University of Chicago professor Jack Szostak delivered two lectures on the origin of life to an audience of professors, graduate, and undergraduate students the Monday and Tuesday ...

All eyes are on Alnylam as the company awaits entry into the transthyretin amyloid cardiomyopathy market, which currently ...

From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 million upfront, building out another cancer-targeting approach.

In a big breakthrough for cancer treatment, Dr. Vinod Balachandran, a surgeon-scientist at Memorial Sloan Kettering Cancer ...

Ursa Major, a Colorado-based firm, has partnered with Palantir to use the latter's Warp Speed manufacturing OS technology to streamline rocket propulsion manufacturing process.

Earth might be creating microscopic lightning bolts—and this electrical phenomenon could have sparked the chemistry of life ...

New research into how a retrovirus is spreading across populations of wild koalas in Queensland, Australia is leading to a ...

But real lightning would have struck infrequently—and mostly in open ocean, where organic compounds would have quickly ...